Create personalized user journeys with Omnichannel Marketing as a Service.
Empower your marketing operations with AI and Data.
Adopt a future-proof holistic approach to content strategy.
Leverage a suite of professional services for pharma and life sciences.
Develop and enable adaptable pharma and life sciences marketing content.
Enable format-free marketing with content management platform.
The innovation-powered content management platform to produce and distribute high quality digital content
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
When you invest months into a pharmaceutical marketing campaign — carefully crafting messaging, selecting the right channels, analyzing audience insights, and aligning strategies with compliance requirements — you want it to drive meaningful engagement and deliver measurable results. But what if, despite all that effort, your campaign falls flat? Low response rates, disengaged healthcare providers, and minimal impact on prescribing behaviors — what went wrong?
For many pharma marketers, the issue isn’t the quality of the campaign itself — it’s the foundation it was built on: HCP segmentation. Without accurate data, a deep understanding of market dynamics, and the ability to navigate regulatory constraints, even the most well-designed campaigns risk missing the mark. Identifying the right HCPs, understanding their needs, and delivering relevant messaging at the right time is crucial — but easier said than done.
So how can pharma companies create a segmentation strategy that drives real engagement? Let’s explore the challenges, best practices, and innovative approaches that can reshape how your brand connects with HCPs.
HCP segmentation, or healthcare provider segmentation, is the process of categorizing healthcare professionals (HCPs) into distinct groups based on specific characteristics, preferences, and behaviors. These criteria may include professional title, specialty, practice setting, prescribing habits, patient population, or geographical location.
HCP segmentation helps healthcare and pharmaceutical companies tailor marketing, communication, and outreach strategies to better target and engage each segment.
In marketing, we instinctively understand that our target audience is a diverse mix of people. Yet, the goal is always to remain relevant to as many as possible. In other words, instead of offering everyone at a party a glass of wine and a steak, you want to cater to those who won’t go for that first option.
The same applies to HCPs. Physicians are diverse, and expecting a single eDetailing slide focused on patient challenges or costs to resonate with everyone is unrealistic. This brings us to audience segmentation. At first glance, it might seem that more segments equal better personalization.
However, this isn’t necessarily true. Here’s why:
Therefore, it’s critical to understand what audience segmentation should and should not be:
A good medical representative will know that trying to sell the same medication to a cardiologist and a general practitioner using identical messaging would be unwise. One is focused on managing complex cardiovascular conditions, while the other sees a variety of cases daily. If your approach doesn’t align with their priorities, your message gets lost in the noise.
Pharmaceutical companies need segmentation because not all HCPs are the same — they have different specialties, prescribing habits, levels of experience, and even preferences for how they receive medical information. A one-size-fits-all marketing strategy won’t cut it.
HCPs are busy. Between patient consultations, research, and staying up to date with medical advancements, they don’t have time for irrelevant marketing messages. But when pharmaceutical companies tailor their outreach — such as sending clinical trial data to specialists or patient-friendly medication guides to primary care physicians — engagement surges. The Institute of Data cites a 5.3x rise in click-through rates when targeted ads are used.
For example, an oncologist may be interested in the latest immunotherapy advancements, while a general practitioner may need straightforward prescribing guidelines for a broad patient population. By segmenting these groups, you can ensure that your marketing efforts and messages are precise, relevant, and valuable.
Marketing budgets seem to be always too tight (and often are in reality), and in the pharmaceutical industry the story goes the same. Every dollar counts. Segmentation helps companies focus their resources on high-value HCP groups rather than spreading efforts too thin.
For instance, if a new diabetes medication is best suited for endocrinologists and internal medicine specialists, there’s little benefit in marketing it to dermatologists. A targeted strategy ensures that marketing spend is directed toward the most receptive audience, leading to a stronger return on investment (ROI).
Reaching physicians at the optimal time and through the right channels can mean the difference between HCP engagement and indifference. Some doctors prefer email updates, while others engage more with medical webinars or in-person conferences.
A hospital-based specialist might respond well to detailed case studies shared via peer-reviewed journals, whereas a busy family physician might engage more with quick, digestible insights in a mobile-friendly format. Segmentation allows pharmaceutical companies to optimize not only what they say, but also when and how they say it.
In an industry where countless companies are vying for HCP attention, segmentation helps brands stand out by providing value beyond just promoting a product. When pharma companies deliver the right content to the right audience at the right time, they position themselves as trusted partners rather than just another sales force.
While segmentation is key for targeted marketing, it comes with several challenges that can impact effectiveness. Understanding these hurdles allows for better planning and strategy refinement.
Accurate segmentation relies on high-quality, up-to-date data, yet obtaining this information can be difficult due to ethical guidelines and privacy restrictions. Incomplete or outdated records lead to misaligned messaging and missed HCP engagement opportunities.
The pharmaceutical industry is constantly evolving — new therapies, shifting regulations, and changing HCP preferences make it difficult to maintain effective segmentation strategies. Your brand must ensure your approach is dynamic and adaptable, incorporating real-time insights to stay relevant.
Developing and executing a segmentation strategy requires time, personnel, and budget, yet many pharmaceutical companies face resource limitations. Poor allocation can lead to delays, inefficiencies, and an inability to personalize engagement at scale. So make sure you look into those automation tools to help you optimize resources.
Even with precise segmentation, HCPs are busy professionals with limited time for promotional content. Identifying the right communication channels and engagement triggers is key for breaking through the noise.
Strict regulations dictate how the pharmaceutical industry interacts with physicians, affecting everything from sales rep visits to digital outreach. While compliance is non-negotiable, it also limits traditional marketing tactics, requiring brands to innovate within approved frameworks — such as leveraging non-promotional content, scientific exchanges, and digital-first engagement models.
Although segmentation is about dividing your customers into groups based on basic criteria like location and practice, it should also be about needs, behaviors, and decision-making processes. That is, if you want to get meaningful engagement. Let’s discuss a step-by-step plan how you can get your HCP marketing right.
The first step in effective segmentation is defining the characteristics that truly differentiate one HCP group from another. Key factors include:
Behavioral data is just as critical in effective segmentation, helping marketers understand how HCPs interact with brands and make treatment decisions:
Data is the backbone of segmentation, which is why you must collect a mix of demographic, professional, and behavioral information to build meaningful profiles. Data can come from multiple sources — CRM systems, surveys, industry reports, and third-party databases.
Insights from past interactions, such as engagement with emails, participation in webinars, or responses to marketing campaigns, can also provide valuable behavioral indicators.
Once collected, this data should be organized to identify key patterns. For example, some specialists may show strong engagement with digital content, while others prefer in-person educational events. Analyzing these behaviors allows you to refine your segmentation model, ensuring that communication strategies align with HCP preferences. Determining patterns is where artificial intelligence usually shines, so consider researching good AI-powered tools to help you with the task.
With clearly defined segments, the next step is developing content that resonates. A highly specialized surgeon may require detailed clinical trial data and real-world evidence before considering a new treatment, while a general practitioner may need easy-to-digest prescribing guidelines for a broad patient population.
Adapting content formats is just as important as tailoring messaging. Busy physicians might engage more with quick, mobile-friendly updates, while specialists may prefer in-depth research articles or expert-led webinars. Instead of taking a one-size-fits-all approach, pharma companies should align their content strategy with the specific needs of each segment.
However, creating personalized content for multiple HCP segments can quickly become overwhelming — especially when pharma marketers need to ensure consistency across global markets, comply with MLR approvals, and optimize content for various platforms. Here you might want to consider modular content strategy.
Modular content allows marketers to build and scale tailored communications by working with pre-approved, adaptable content blocks. Instead of creating separate materials for each segment or channel, pharma teams can pull from a library of MLR-approved, channel-agnostic content modules to assemble marketing assets faster.
For example, let’s say you’re promoting a new cardiovascular drug to different HCP groups. You could start with key content components such as: a clinical trial summary with efficacy data, a chart comparing drug effectiveness against current treatment options, patient case studies, and call to actions (CTAs).
From these core content modules, you can assemble personalized materials for your different segments:
Each piece is built from the same core content but tailored for different audiences, ensuring relevance without recreating materials from scratch.
The best thing about modulr content is that these modules can be adapted to different channels. And in case you’re using eWizard, you can publish this content to different channels too.
So whether you need to create a short visual post featuring a compelling statistic module about the drug’s effectiveness for social media, or an eDetailer featuring interactive content blocks, allowing reps to tailor discussions based on an HCP’s interests, you can easily do that with much less manual work.
HCPs engage with content across multiple platforms — emails, professional networking sites, virtual conferences, and even in-person meetings with medical representatives. A fragmented approach risks losing engagement, but an omnichannel strategy ensures consistency across all touchpoints.
For example, if an HCP attends a virtual panel discussion on a new therapy, they could receive follow-up materials via email, an invitation to a more detailed webinar, or access to a case study relevant to their specialty. By leveraging CRM systems and automation tools, pharma marketers can track engagement in real time and refine their approach based on how different HCP segments interact with the content.
To help you with your channel distribution debate, here’s what Avant Healthcare found in their 2024 HCP survey regarding favorite content formats (by specialty).
Age matters too, as the report highlights that HCPs born in 1980 or earlier consistently placed higher value on content centered around key opinion leaders (KOL) interactions compared to their younger colleagues born in 1981 or later. While both groups ranked live, in-person KOL-presented programs among their top five content formats, younger HCPs showed significantly less interest in virtual KOL programs and KOL videos than their older counterparts.
In contrast, younger generations preferred content that maximized efficiency, such as one-page downloadable resources, articles, or blog-style content. They also favored podcasts, which offer the flexibility to be consumed on the go.
Segmentation isn’t a static process. As healthcare industry evolves, new treatments emerge, and HCP behaviors shift, pharma companies must continuously refine their approach. Regularly analyzing data and adjusting segmentation models ensures that your marketing efforts remain effective.
And to make this process smooth, collaboration between marketing and sales teams is essential. That way your customer experience will be seamless across digital and in-person channels.
Pharma marketers know that segmentation is vital — but executing it at scale, keeping it dynamic, and ensuring seamless engagement is another challenge entirely. Manual segmentation can be time-consuming and rigid, making it difficult to adapt to changing HCP behaviors and preferences. This is where a customer relationship management (CRM) system transforms the process from static to strategic.
Manual segmentation is time-consuming. CRMs automate classification based on prescribing behavior, engagement history, and specialty, ensuring lists update dynamically. For instance, if an HCP engages with a clinical study, the CRM instantly moves them to a high-priority list for targeted follow-up.
HCP behavior changes — your segmentation should too. CRMs adjust outreach based on content interactions, channel preferences, and prescribing trends: behavior-based triggers prompt personalized follow-ups, AI-driven insights predict which HCPs are most likely to engage or prescribe.
CRMs track HCP consent, regulatory requirements, and engagement history to ensure compliant outreach. They also align sales and marketing by providing real-time insights to sales reps before interactions. For example, before a sales call, the CRM highlights recent engagement, content downloads, and preferred channels, allowing for more relevant conversations.
Reaching HCPs today isn’t just about being in multiple channels — it’s about strategically guiding them through a decision journey while adapting to evolving content consumption habits. As digital preferences shift, pharma marketers must rethink where, when, and how they engage their audience.
HCPs increasingly favor self-guided learning, bite-sized content, and on-demand access. Younger professionals are embracing podcasts, ranking them among their top four preferred channels, while KOL-led content continues to influence prescribing decisions — but in different formats based on specialty and age. A rigid channel strategy no longer works, adaptability is key.
An omnichannel approach isn’t just about being everywhere — it’s about creating seamless progression. A KOL webinar might introduce a treatment concept, followed by a short-form video summarizing key takeaways, leading to an interactive case study that encourages deeper engagement. Each touchpoint should naturally lead HCPs to the next step.
Marketers must be strategic when choosing platforms. Some third-party sites provide broad reach but limit access to HCP engagement data, while owned channels like HCP portals or gated webinars offer deeper insights into audience behavior. Understanding these trade-offs is critical for optimizing both engagement and data collection.
Doctors aren’t just consuming content in medical journals — many are engaging with educational TikTok videos, peer-led discussions on Reddit, and interactive microlearning modules. Instead of dismissing emerging channels, brands should experiment with small-scale tests to identify where meaningful engagement can happen.
A compelling narrative is what keeps HCPs engagement up across channels. Whether through a thought-provoking campaign, immersive visuals, or real-world case studies, pharma brands must ensure their message remains consistent yet adaptable to different learning styles.
Reaching the right healthcare professionals isn’t just about identifying them — it’s about delivering relevant content in the right format, at the right time. That’s where we help.
With eWizard, you can create and manage personalized content efficiently, ensuring consistency across channels without extra manual effort or coding skills.
Our team also provides expert guidance on adopting the right technology, implementing modular content strategies, and improving omnichannel engagement — so your marketing reaches doctors in a way that actually resonates.
If you’re looking to improve how you engage with HCPs, we’re here to help. Let’s talk.
Talk to our experts and discover how innovation and insight drive your digital success.
